Related Experiment Video
Updated: Aug 8, 2026
In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
[New process for screening of drugs in experimental infection with Trypanosoma cruzi]
R Campos1, V Amato Neto, H B de Souza
1Laboratório de Investigação Médica-Parasitologia, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, Brasil.
Abstract:
We propose a screening process for detection of therapeutic activity of drugs against experimental infection with Trypanosoma cruzi. It is based on the use of infected triatominae that are fed on mice which have received the study drug. Blood meals are made at different time schedule in order to adapt with serum drug levels. The digestive tube of the hemiptera will, thus, work as a suitable structure for examination. In a initial observation, benzonidazole was used, and was shown to be only partially active at least in the conditions of this new procedure.
Insights
This study introduces a novel method for screening drug efficacy against Trypanosoma cruzi infections using infected insects. Benznidazole showed limited activity in this initial assay, suggesting a need for further optimization.
Area of Science:
- Parasitology
- Drug Discovery
- Infectious Diseases
Background:
- Chagas disease, caused by Trypanosoma cruzi, remains a significant global health challenge.
- Current therapeutic options for Chagas disease are limited and can have severe side effects.
- Development of new, effective drugs is crucial for managing Trypanosoma cruzi infections.
Purpose of the Study:
- To establish a novel in vivo screening platform for evaluating the therapeutic potential of drugs against Trypanosoma cruzi.
- To assess the feasibility of using infected triatominae fed on drug-treated mice as a model system.
- To conduct an initial evaluation of benzonidazole's activity using this new screening method.
Main Methods:
- A new drug screening process was developed utilizing infected triatominae (hemiptera).
- Triatominae were fed on mice that had received the drug under investigation.
- Blood meals were collected at various time points to correlate with serum drug concentrations.
- The digestive tract of the triatominae served as the examination site.
Main Results:
- The proposed screening method was successfully implemented.
- Benzonidazole was tested as a reference drug.
- Benzonidazole demonstrated only partial therapeutic activity under the conditions of this new procedure.
Conclusions:
- The developed screening process offers a potentially valuable tool for identifying new anti-Trypanosoma cruzi agents.
- Further studies are warranted to optimize the screening conditions and validate the method with a broader range of compounds.
- The partial activity observed for benzonidazole highlights the importance of assay conditions in drug efficacy evaluation.
